Vanda Pharma Stock (NASDAQ: VNDA) stock price, news, charts, stock research, profile.
Open | $4.500 |
Close | $4.620 |
Volume / Avg. | 821.939K / 2.315M |
Day Range | 4.450 - 4.625 |
52 Wk Range | 3.295 - 7.000 |
Market Cap | $260.064M |
P/E Ratio | 112.000 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 5.45% |
Days to Cover | 3.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vanda Pharma (NASDAQ: VNDA) through any online brokerage.
Other companies in Vanda Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).
The latest price target for Vanda Pharma (NASDAQ: VNDA) was reported by Jefferies on Friday, February 25, 2022. The analyst firm set a price target for 12.00 expecting VNDA to rise to within 12 months (a possible 165.49% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Vanda Pharma (NASDAQ: VNDA) is $4.5199 last updated April 26, 2024 at 5:46 PM EDT.
There are no upcoming dividends for Vanda Pharma.
Vanda Pharma’s Q2 earnings are confirmed for Thursday, July 25, 2024.
There is no upcoming split for Vanda Pharma.
Vanda Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.